Literature DB >> 16601072

Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway.

Tommaso Simoncini1, Camila Scorticati, Paolo Mannella, Ahmed Fadiel, Maria S Giretti, Xiao-Dong Fu, Chiara Baldacci, Silvia Garibaldi, Antonella Caruso, Letizia Fornari, Frederick Naftolin, Andrea R Genazzani.   

Abstract

Sex steroids control cell movement and tissue organization; however, little is known of the involved mechanisms. This report describes the ongoing dynamic regulation by estrogen of the actin cytoskeleton and cell movement in human vascular endothelial cells that depends on rapid activation of the actin-regulatory protein moesin. Moesin activation is triggered by the interaction of the C-terminal portion of cell membrane estrogen receptor alpha with the G protein Galpha(13), leading to activation of the small GTPase RhoA and of the downstream effector Rho-associated kinase. The resulting phosphorylation of moesin on Thr(558) is the means of moesin's binding to actin and the remodeling of the actin cytoskeleton. This cascade of events ensues within minutes of estradiol administration and results in changes in cell morphology and to the development of specialized cell membrane structures such as ruffles and pseudopodia that are necessary for cell movement. These findings expand our knowledge of the basis of estrogen's effects on human cells, including the regulation of actin assembly, cell movement and migration. They highlight novel pathways of signal transduction of estrogen receptor alpha through nontranscriptional mechanisms. Furthermore, exposure of this estrogen receptor-dependent, nongenomic action of estrogen on human vascular endothelial cells is especially relevant to the present interest in the role of estrogen in cardiovascular protection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601072     DOI: 10.1210/me.2005-0259

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  69 in total

Review 1.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

2.  Novel bioactivity of NHERF1 in corneal neovascularization.

Authors:  Peng Chen; Ye Wang; Lingling Yang; Changyou Li; Yao Wang; Lixin Xie; Yiqiang Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-10       Impact factor: 3.117

Review 3.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

4.  Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.

Authors:  Nicolas G Azios; Lakshmi Krishnamoorthy; Micheleen Harris; Luis A Cubano; Michael Cammer; Surangani F Dharmawardhane
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

5.  Cell Interactome: Good Neighbors or Bad Neighbors.

Authors:  A Fadiel; Kd Eichenbaum; Y Xia
Journal:  Biosci Hypotheses       Date:  2008

6.  Sonic hedgehog induces angiogenesis via Rho kinase-dependent signaling in endothelial cells.

Authors:  Marie-Ange Renault; Jérôme Roncalli; Jörn Tongers; Tina Thorne; Ekaterina Klyachko; Sol Misener; Olga V Volpert; Shanu Mehta; Aaron Burg; Corinne Luedemann; Gangjian Qin; Raj Kishore; Douglas W Losordo
Journal:  J Mol Cell Cardiol       Date:  2010-05-15       Impact factor: 5.000

7.  Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.

Authors:  Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2013-10-04       Impact factor: 5.858

8.  Phytoestrogen genistein protects against endothelial barrier dysfunction in vascular endothelial cells through PKA-mediated suppression of RhoA signaling.

Authors:  Zhenquan Jia; Wei Zhen; Pon Velayutham Anandh Babu; Dongmin Liu
Journal:  Endocrinology       Date:  2012-12-18       Impact factor: 4.736

Review 9.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

Review 10.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.